361 related articles for article (PubMed ID: 17164822)
21. From neurobiology to treatment: progress against addiction.
Nestler EJ
Nat Neurosci; 2002 Nov; 5 Suppl():1076-9. PubMed ID: 12403990
[TBL] [Abstract][Full Text] [Related]
22. Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism.
Lanteri C; Salomon L; Torrens Y; Glowinski J; Tassin JP
Neuropsychopharmacology; 2008 Jun; 33(7):1724-34. PubMed ID: 17805311
[TBL] [Abstract][Full Text] [Related]
23. Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat.
Fadda P; Scherma M; Fresu A; Collu M; Fratta W
Synapse; 2003 Oct; 50(1):1-6. PubMed ID: 12872287
[TBL] [Abstract][Full Text] [Related]
24. Cocaine, dopamine and the endogenous opioid system.
Kreek MJ
J Addict Dis; 1996; 15(4):73-96. PubMed ID: 8943583
[TBL] [Abstract][Full Text] [Related]
25. New insights and treatments: opiate withdrawal and cocaine addiction.
Gold MS; Dackis CA
Clin Ther; 1984; 7(1):6-21. PubMed ID: 6394130
[TBL] [Abstract][Full Text] [Related]
26. Noradrenergic modulation of ephedrine-induced hypophagia.
Wellman PJ; Miller DK; Ho DH
Synapse; 2003 Apr; 48(1):18-24. PubMed ID: 12557268
[TBL] [Abstract][Full Text] [Related]
27. The neurokinin-1 receptor in addictive processes.
Schank JR
J Pharmacol Exp Ther; 2014 Oct; 351(1):2-8. PubMed ID: 25038175
[TBL] [Abstract][Full Text] [Related]
28. Brain catecholamines during ethanol administration, effect of naloxone on brain dopamine and norepinephrine responses to withdrawal from ethanol.
Guaza C; Borrell S
Pharmacol Res Commun; 1985 Dec; 17(12):1159-67. PubMed ID: 4095124
[TBL] [Abstract][Full Text] [Related]
29. Neurobiology of addiction: insight from neurochemical imaging.
Urban NB; Martinez D
Psychiatr Clin North Am; 2012 Jun; 35(2):521-41. PubMed ID: 22640769
[TBL] [Abstract][Full Text] [Related]
30. The dopamine D3 receptor and drug dependence: effects on reward or beyond?
Le Foll B; Goldberg SR; Sokoloff P
Neuropharmacology; 2005 Sep; 49(4):525-41. PubMed ID: 15963538
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological approaches to cocaine addiction.
Dackis CA; Gold MS
J Subst Abuse Treat; 1985; 2(3):139-45. PubMed ID: 3912517
[TBL] [Abstract][Full Text] [Related]
32. Role of Dopamine Signaling in Drug Addiction.
Chen W; Nong Z; Li Y; Huang J; Chen C; Huang L
Curr Top Med Chem; 2017; 17(21):2440-2455. PubMed ID: 28474551
[TBL] [Abstract][Full Text] [Related]
33. Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward.
Olson VG; Heusner CL; Bland RJ; During MJ; Weinshenker D; Palmiter RD
Science; 2006 Feb; 311(5763):1017-20. PubMed ID: 16484499
[TBL] [Abstract][Full Text] [Related]
34. Brain substrates for increased drug seeking during protracted withdrawal.
Aston-Jones G; Harris GC
Neuropharmacology; 2004; 47 Suppl 1():167-79. PubMed ID: 15464135
[TBL] [Abstract][Full Text] [Related]
35. Individual differences in ethanol self-administration following withdrawal are associated with asymmetric changes in dopamine and serotonin in the medial prefrontal cortex and amygdala.
Carlson JN; Drew Stevens K
Alcohol Clin Exp Res; 2006 Oct; 30(10):1678-92. PubMed ID: 17010135
[TBL] [Abstract][Full Text] [Related]
36. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.
Berridge CW; Stalnaker TA
Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041
[TBL] [Abstract][Full Text] [Related]
37. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
[TBL] [Abstract][Full Text] [Related]
38. Rapid regulation of the dopamine transporter: role in stimulant addiction?
Zahniser NR; Sorkin A
Neuropharmacology; 2004; 47 Suppl 1():80-91. PubMed ID: 15464127
[TBL] [Abstract][Full Text] [Related]
39. Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis.
Egli RE; Kash TL; Choo K; Savchenko V; Matthews RT; Blakely RD; Winder DG
Neuropsychopharmacology; 2005 Apr; 30(4):657-68. PubMed ID: 15602500
[TBL] [Abstract][Full Text] [Related]
40. Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests.
Zernig G; Ahmed SH; Cardinal RN; Morgan D; Acquas E; Foltin RW; Vezina P; Negus SS; Crespo JA; Stöckl P; Grubinger P; Madlung E; Haring C; Kurz M; Saria A
Pharmacology; 2007; 80(2-3):65-119. PubMed ID: 17570954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
